NEW RESOURCE: Scaling trusted, high-impact AI care navigation
New Resource: DECODE CRS: Accelerating safer, scalable immunotherapy
New from the AMA: The physicians role in the AI era

The challenge
Digital clinical measures that are meaningful to patients are revolutionizing how we evaluate health. Yet, some of the greatest value associated with digital endpoints remains out of reach. This is especially true for novel digital clinical measures that capture symptoms of disease that haven’t been measured before.
The solution
To address this, DATAcc has developed the Validating Novel Digital Clinical Measures resources for DHT developers and biostatisticians.
Adopting these resources in your work will unlock the full potential of novel digital clinical measures for scientific and clinical decision-making, ultimately for new therapies to reach patients. These resources will accelerate the adoption of digital endpoints in clinical research and related regulatory interactions.
Use these resources to establish a clear decision process for designing and conducting analytical validation for your digital clinical measure of interest, whether it is for a novel or previously assessed outcome.

Accelerate your analytical validation studies and streamline your interaction with regulators

Support your colleagues in developing statistically sound analytical validation studies and access a simulation toolkit to quickly game out more complex reference measure comparisons

This work was conducted as a Public-Private Partnership (PPP) with the FDA’s Center for Drug Evaluation and Research (CDER).
This work was supported by the PPP CDER liaison and a group of experts in the life sciences who made invaluable contributions.
The Statistical Advisory Committee
Andrew Potter, Andrew Trigg, Berend Terluin, Bohdana Ratitch, Chakib Battioui, Chen Chen, Colleen Russell, David Reasner, Eric Daza, Frank Pétavy, Jakob Bjorner, Joss Langford, Kevin Weinfurt, Leif Simmatis, Libby Floden, Robert Wright, Rolando Acosta, Sachin Shah, Valentin Hamy, Yiorgos Christakis






DATAcc by DiMe’s V3+ Framework established a robust and widely adopted approach to:
Analytical validation can be especially complex because it relies on a fit-for-purpose reference measure, which can be difficult to obtain.

For a quick refresher on the V3+ Framework, enroll in the Digital Medicine Academy’s 30-minute course.